El Kihel Laïla, Clément Monique, Bazin Marc-Antoine, Descamps Géraldine, Khalid Mohamed, Rault Sylvain
Centre d'Etudes et de Recherche sur le Médicament de Normandie, UPRES EA-3915, FR CNRS INC3M, Université de Caen Basse-Normandie, U.F.R. des Sciences Pharmaceutiques, 5 rue Vaubénard, 14032 Caen Cedex, France.
Bioorg Med Chem. 2008 Sep 15;16(18):8737-44. doi: 10.1016/j.bmc.2008.07.046. Epub 2008 Jul 23.
Six new synthetic bile acid derivatives were synthesized and tested in vitro against various human cancer cells (glioblastoma multiforme (GBM), multiple myeloma (KMS-11), and colonic carcinoma (HCT-116) cell lines. The best activity was obtained with compound IIIb on multiple myeloma cells (LD(50): 8.5+/-0.5 microM). This activity was associated with Mcl-1 and PARP-1 cleavage, inhibition of NFkappaB signaling, and DNA fragmentation, demonstrating an apoptotic cell death signaling pathway.
合成了六种新的合成胆汁酸衍生物,并在体外针对各种人类癌细胞(多形性胶质母细胞瘤(GBM)、多发性骨髓瘤(KMS - 11)和结肠癌细胞系(HCT - 116))进行了测试。化合物IIIb对多发性骨髓瘤细胞表现出最佳活性(半数致死剂量(LD(50)):8.5±0.5微摩尔)。这种活性与Mcl - 1和PARP - 1的切割、NFκB信号传导的抑制以及DNA片段化有关,表明存在凋亡细胞死亡信号通路。